Search
forResearch 3 of 12
- Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Cemiplimab-Induced Alopecia Areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →